Discover how the Sunvou TM2120 FeNO device brings precision, efficiency, and clinical confidence into everyday respiratory diagnostics. This video provides a clear walkthrough of the device in action, demonstrating how exhaled nitric oxide (FeNO) measurement is performed and why it plays a critical role in modern asthma management.

The video begins by introducing the TM2120 as a reliable solution for measuring airway inflammation through breath analysis. By capturing exhaled nitric oxide levels, the device enables healthcare professionals to assess inflammation in both large and small airways, as well as the upper respiratory tract. This multi-level capability—covering FeNO50, FeNO200 (CaNO), and FnNO—ensures a comprehensive understanding of a patient’s respiratory condition.

As the demonstration progresses, viewers are guided through the measurement process. The TM2120 operates in an online mode, directly connected to the patient during sampling, allowing for real-time data acquisition. The video highlights how the system delivers fast, accurate readings, helping clinicians make informed decisions without unnecessary delays. (Sunvou)

Ease of use is another key focus. The interface is designed to simplify workflow, making it suitable for both experienced professionals and new users. The video also emphasizes the device’s flexible calibration options, including self-calibration and gas calibration, ensuring consistent performance across clinical environments.

Importantly, the TM2120 supports advanced biomarker detection, including nitric oxide (NO), hydrogen sulfide (H₂S), and carbon monoxide (CO). This expands its diagnostic value beyond standard FeNO testing, offering deeper insights into respiratory health.

Overall, the video showcases the TM2120 as a powerful, user-friendly tool that enhances diagnostic accuracy, supports personalized treatment decisions, and strengthens confidence in asthma management.